Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population

被引:2
作者
Hu, Xue [1 ]
Ding, Wei [2 ]
Jin, Xinye [3 ]
Wang, Jia [4 ]
Zou, Dajin [5 ]
Chen, Yue [6 ]
机构
[1] Shidong Hosp, Dept Endocrinol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Geriatr, Shanghai, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China
[4] Gen Hosp Jinan Mil Reg Chinese Peoples Liberat Ar, Dept Endocrinol, Jinan, Shandong, Peoples R China
[5] Second Mil Med Univ, Dept Endocrinol, Changhai Hosp, 168 ChangHai Rd, Shanghai 200433, Peoples R China
[6] Shanghai Baoshan Tradit Chinese Med Integrated Ho, Dept Endocrinol, 181 YouYi Rd, Shanghai 201900, Peoples R China
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2018年 / 35卷 / 01期
关键词
acne; SRD5A2; gene; V89L polymorphism; (TA)n repeat polymorphism; PROSTATE-CANCER RISK; STEROID; 5-ALPHA-REDUCTASE; ASSOCIATION; TYPE-2;
D O I
10.5114/ada.2018.73162
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Several studies have reported that the V89L and TA repeat polymorphisms [(TA)n] of the SRD5A2 gene were associated with SRD5A2 activity. The activity of dihydrotestosterone, which is converted from testosterone by SRD5A2, is responsible for sebum secretion and the formation of acne. We hypothesized that abnormalities in SRD5A2 action could contribute to the formation of acne. Aim: To study whether the structural change of the SRD5A2 gene may affect the risk of acne in patients with normal serum testosterone levels. Material and methods: Genotyping of rs523349 and (TA) n of SRD5A2 was performed in 49 Chinese acne patients with significant improvements with SRD5A2 inhibitor-finasteride but normal serum testosterone levels, and in 50 healthy Chinese age-matched controls without acne. Results: There was no significant difference between the two groups in the frequencies of V and L alleles and VV, VL, and LL genotypes of V89L (chi(2) test, p > 0.5). (TA) n polymorphic repeat sites are 5 alleles (TA0, TA3, TA6, TA9, TA12) in our population. The differences in S and L allele frequencies between the two groups were statistically significant (p < 0.005). People with a longer (n >= 6) allele of the (TA) n repeat polymorphism had a higher risk of having acne than those with a shorter (n < 6) allele (OR = 3.52, 95% CI: 1.73-7.16). Conclusions: This study suggests that SRD5A2 polymorphisms might be associated with acne risk. This is the first report focusing on the Chinese population according to our knowledge. Further large sample studies may be required to confirm the association and to assess any interactions with environmental factors.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 23 条
[1]   Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5α-reductase during prostate cancer progression [J].
Akalu, A ;
Elmajian, DA ;
Highshaw, RA ;
Nichols, PW ;
Reichardt, JKV .
JOURNAL OF UROLOGY, 1999, 161 (04) :1355-1358
[2]   The influence of genetics and environmental factors in the pathogenesis of acne: A twin study of acne in women [J].
Bataille, V ;
Snieder, H ;
MacGregor, AJ ;
Sasieni, P ;
Spector, TD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (06) :1317-1322
[3]   Role of hormones in pilosebaceous unit development [J].
Deplewski, D ;
Rosenfield, RL .
ENDOCRINE REVIEWS, 2000, 21 (04) :363-392
[4]   A comparison of current acne grading systems and proposal of a novel system [J].
Doshi, A ;
Zaheer, H ;
Stiller, MJ .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1997, 36 (06) :416-418
[5]  
Goulden V, 1999, BRIT J DERMATOL, V141, P297
[6]  
Hsing AW, 2001, CANCER EPIDEM BIOMAR, V10, P1077
[7]  
[金昕晔 JIN Xin-ye], 2009, [第二军医大学学报, Academic Journal of Second Military Medical University], V30, P1131
[8]   Effect of finasteride 5 mg (Proscar®) on acne and alopecia in female patients with normal serum levels of free testosterone [J].
Kohler, Claudia ;
Tschumi, Katharina ;
Bodmer, Christine ;
Schneiter, Martin ;
Birkhaeuser, Martin .
GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (03) :142-145
[9]   Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population [J].
Li, ZH ;
Habuchi, T ;
Mitsumori, K ;
Kamoto, T ;
Kinoshitu, H ;
Segawa, T ;
Ogawa, O ;
Kato, T .
JOURNAL OF UROLOGY, 2003, 169 (06) :2378-2381
[10]  
Makridakis N, 2000, CANCER RES, V57, P1020